AMTB Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Amerant Bancorp Inc (AMTB) is not a strong buy at this moment for a beginner investor with a long-term focus. While there are some positive technical indicators and a slight upward price movement, the company's financial performance shows significant declines in net income and EPS, and hedge funds are heavily selling the stock. Additionally, there are no significant recent news or catalysts to support a strong buy decision.
The MACD is positive and expanding, indicating bullish momentum. The RSI is neutral at 70.398. Moving averages are bullish (SMA_5 > SMA_20 > SMA_200). The stock is trading above key support levels, with resistance at R1: 21.623 and R2: 22.043. However, the stock's recent candlestick pattern suggests a 40% chance of a -0.5% drop in the next day and a -3.18% drop in the next month.
Analysts have raised price targets recently, with Piper Sandler and Raymond James expressing optimism about the company's future following management changes and ongoing transition efforts.
Hedge funds are selling heavily, with a 1633.98% increase in selling activity last quarter. Financial performance in Q4 2025 showed a significant drop in net income (-84.00% YoY) and EPS (-82.50% YoY). No recent news or significant insider activity to drive positive sentiment.
In Q4 2025, revenue increased by 14.56% YoY to $86,666,000. However, net income dropped significantly by -84.00% YoY to $2,701,000, and EPS fell by -82.50% YoY to 0.07. Gross margin remained unchanged.
Analysts have mixed views. Keefe Bruyette maintains a Market Perform rating with a $23 price target. Piper Sandler raised its target to $25 and maintains an Overweight rating, citing potential for improvement despite past challenges. Raymond James raised its target to $23 with an Outperform rating, citing positive risk-reward following management changes.
